NM/CT 860
At a Glance
NM/CT 860 is a SPECT/CT system designed for high-performance clinical environments
It combines the SPECT and productivity enhancements of the 800 Series with an optimal balance of CT technology. Technology with the thin-slice CT performance you need for all of your SPECT/CT protocols and the most common standalone CT exams, without overlapping with your other CT assets. NM/CT 860 is exactly what you need to continue to grow and strengthen the clinical value of nuclear medicine by making it more accessible in routine care.
Features
A SPECT/CT system for true discovery
You are committed to making true discovery even more accessible to patients. That's why we created NM/CT 860, to help you overcome any financial and operational challenges in your way, so you can continue to pursue true discovery.
TECHNOLOGY
Optimized for everyday imaging
PRODUCTIVITY
Switch to an all-digital workflow with SmartConsole
PRODUCTIVITY
One home for all of your molecular images
Capability
The right mix of SPECT and CT capability
Until now, many advanced hybrid and quantitative protocols have been limited to research institutions with the extra resources needed to provide complex protocols. Through SmartConsole and Xeleris™, NM/CT 860 makes these protocols available in routine settings by reducing the resources needed to perform them.
A simpler way to bring everything together
Stay on top of the latest trends in imaging
A CT that stands out when it stands alone
DISCLAIMERS
1. In clinical practice, Evolution options1a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit1b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.
1a. Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.
1b. Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.
2. Compared to LEHR collimator, with Step & Shoot scan mode (for SPECT) / without Clarity 2D (for Planar). As demonstrated in phantom testing using a bone scan protocol, Evolution processing (for SPECT), and a model observer. Because model observer results may not always match those from a human reader, the actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice. A radiologist should determine the appropriate scan time/dose for the particular clinical task.
3. As demonstrated in phantom testing using a model observer. For SPECT, compared to using the LEHR Collimator and a SPECT Step & Shoot acquisition. For Planar, compared to using LEHR without Clarity 2D.
4. In clinical practice, the use of ASiR or VISR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.
1a. Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.
1b. Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.
2. Compared to LEHR collimator, with Step & Shoot scan mode (for SPECT) / without Clarity 2D (for Planar). As demonstrated in phantom testing using a bone scan protocol, Evolution processing (for SPECT), and a model observer. Because model observer results may not always match those from a human reader, the actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice. A radiologist should determine the appropriate scan time/dose for the particular clinical task.
3. As demonstrated in phantom testing using a model observer. For SPECT, compared to using the LEHR Collimator and a SPECT Step & Shoot acquisition. For Planar, compared to using LEHR without Clarity 2D.
4. In clinical practice, the use of ASiR or VISR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.